Table 3.
Surgical details and postop. course
| All recipients | Paired recipients | |||||
|---|---|---|---|---|---|---|
| PRT | TRT | p | nTRT | sTRT | p | |
| CIT (h) | 14.7 (SD: 4.3) | 14.4 (SD: 4.8) | n.s. | 14.9 | 12.8 | n.s. |
| HT (min.) | 42 (SD: 17) | 35 (SD: 13) | 0.02 | 38 | 36 | n.s. |
| OT (min.) | 132 (SD: 40) | 152 (SD: 37) | 0.02 | 118 | 142 | n.s. |
| Stent use % | 13.3 | 25.0 | n.s. | 11.1 | 11.1 | n.s. |
| DGF % | 22.4 | 60.0 | 0.00009 | 22.2 | 44.4 | n.s. |
| Haematoma % | 16.6 | 35.0 | 0.031 | 22.2 | 55.6 | n.s. |
| Lymphocele % | 4.0 | 0 | n.s. | 11.1 | 0 | n.s. |
| Vascular complications % | 2.94 | 5.0 | n.s. | 0 | 11.1 | n.s. |
| Ureter complications % | 8.7 | 20.0 | n.s (0.08) | 11.1 | 33.3 | n.s. |
| Reoperations within 30 days, % | 8.5 | 10.0 | n.s. | 11.1 | 22.2 | n.s. |
| Biopsy % | 22.4 | 40.0 | n.s. (0.06) | 33.3 | 66.7 | n.s. |
| Acute rejection % | 15.9 | 15.0 | n.s. | 22.2 | 22.2 | n.s. |
| Hospital stay (days) | 14.8 | 21.4 | 0.003 | 11.7 | 28.8 | 0.0213 |
Considered signficant if p < 0.05